-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a research article was published in Diabetes Care, an authoritative journal in the field of diabetes .
Researchers aim to evaluate the changes in the prevalence of depression, loneliness and insomnia in elderly patients with type 2 diabetes from 2016 to 2020, and to evaluate these diseases risk factors, including demographic statistical science, frequently-occurring disease rate, BMI, treatment
.
This is a prospective observational study of participants in the AHEAD (Action for Diabetes Health) cohort study
.
The data comes from two assessments before COVID-19 (follow-up 1: April 2016 to June 2018 and follow-up 2: February 2018 to February 2020) and one assessment during COVID-19 (follow-up 3: 2020 July to December of the year)
COVID-19
The study included 2829 adults (63.
2% were women, 60.
6% were white, and the average [SD] age was 75.
6 [6.
0] years)
.
Between the two pre-pandemic visits, the prevalence of mild or severe depressive symptoms did not change significantly (P=0.
V3 has a higher chance of developing mild or severe depressive symptoms compared with women (adjusted odds ratio [OR=1.
4[95%CI=1.
1-1.
7]), non-Hispanic whites (OR=1.
4[95%CI=1.
1] -1.
7])), obesity (OR=1.
3[95%CI=1.
0-1.
5]), in addition to V1 (OR=4.
0[95%CI=2.
9-5.
4]), V2(OR=4.
4[95 %CI was 3.
2-5.
9]) or two follow-ups (OR was 13.
4 [95%CI was 9.
7-18.
4]) reported mild or more severe depressive symptoms related
.
The prevalence of loneliness increased from 12.
It can be seen that during the COVID-19 period, the prevalence of mild or moderate depressive symptoms in elderly diabetic patients is more than 1.
6 times that before the COVID-19 pandemic
.
6 times that before the COVID-19 pandemic
.
Original Source:
Ariana M.
Chao,et al.
Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in US Older Adults With Type 2 Diabetes During the COVID-19 Pandemic: The Look AHEAD Study .
Original Source: Changes in at The Prevalence of Symptoms of Depression, Loneliness, and US Insomnia in Older Adults With Type 2 Diabetes During COVID-19 at The Pandemic: the AHEAD Look at The Study in this message
